| BioNTech". investors.biontech.de. p. 130. Retrieved 28 December 2020. Joe Miller, Clive Cookson (16 December 2020). "FT People of the Year: BioNTech's...

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...

regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...

at BioNTech's laboratories in Mainz, Germany, just days after the SARS-Cov-2 genetic sequence was first made public. In September 2020, BioNTech received...

Pfizer–BioNTech's BNT162b2 COVID-19 vaccine for widespread use. On 11 December, the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19...

African Health Products Regulatory Authority (SAHPRA) approved the Pfizer-BioNTech vaccine (BNT162b2) for section 21 Emergency Use Authorisation. On 1 April...

delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine." By the end of September, Canada will receive the 40 million Pfizer-BioNTech doses. Major General Fortin...

associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. In 2022, she left BioNTech to devote...

Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later...

weakened immune systems. Several COVID‑19 vaccines, such as the Pfizer–BioNTech and Moderna vaccines, use RNA to stimulate an immune response. When introduced...

entrepreneur, and billionaire businessman. He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19...

Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production...

and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in...

Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. Bourla opposes government interference in pharmaceutical...

conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2 (later branded as Comirnaty). This...

had been distributed for use outside of the phase 3 trial. The Pfizer–BioNTech partnership submitted an Emergency Use Authorization (EUA) request to the...

approved the Pfizer-BioNTech vaccine for section 21 Emergency Use Authorisation. A trial ending in March 2021 of the Pfizer-BioNTech's COVID-19 vaccine appeared...

begin mass vaccination with the Pfizer–BioNTech COVID-19 vaccine. In addition, Singapore approves the Pfizer–BioNTech COVID-19 vaccine, with other companies...

Retrieved 11 June 2015. "Pfizer–BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling". Pfizer-BioNTech. Archived from the original on...

Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen...

legal cases between Moderna and Pfizer and BioNTech in various countries, alleging that the Pfizer–BioNTech COVID-19 vaccine violates the patent on Moderna's...

On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional...

magnesium sulfate, potassium phosphate COVID-19 vaccines, mRNA-based (Pfizer-BioNTech COVID-19 Vaccine ) (Moderna COVID-19 Vaccine) Lipids, salts, sucrose, plus...

274,950 doses of the Pfizer–BioNTech vaccine arrived in Indonesia. On 16 September, 2.5 million doses of the Pfizer–BioNTech vaccine and 968,360 doses of...

authority for public use: one DNA vaccine: ZyCoV-D four RNA vaccines: Pfizer–BioNTech, Moderna, Walvax, and Gemcovac twelve inactivated vaccines: Chinese Academy...

company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief...

PEGylated lipid is used as an excipient in both the Moderna and Pfizer–BioNTech vaccines for SARS-CoV-2. Both RNA vaccines consist of messenger RNA, or...

approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals...

study in the New England Journal of Medicine reported that the Pfizer–BioNTech COVID-19 vaccine was 88 percent effective in preventing symptomatic infections...

authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm...